Whenever I meet someone, I’m always asked how to build a successful FemTech & women’s health brand and how we built our global brand identity.
I want to share some insights from my experience over the past two years, working with companies around the world. Based on what I’ve observed, here are 5 key areas to focus on in your strategy to scale your women’s health business without fail:
Community wins:
HempStreet’s Innovative Ayurvedic + Medical Cannabis Formula Shows Strong Promise in Managing Menstrual Cramps :
HempStreet, our ecosystem company focused on advancing women’s health, has achieved a significant breakthrough. Results from a Phase 1 clinical trial reveal strong preliminary evidence supporting the safety and efficacy of their new patent-pending formulation designed for the management of menstrual cramps (dysmenorrhea).
This groundbreaking solution combines the wisdom of Ayurvedic medicine with the therapeutic potential of medical cannabis, offering new hope for millions of women experiencing painful periods.
India is now the 4th largest global medical device manufacturer, and the women’s health market, currently valued at $45 billion, is poised for exponential growth, expected to reach $65 billion by 2030.
🔍 In the report below, discover:
✅ Why Women’s Health Manufacturing is booming in India.
✅ Market size , investment projections & ROI.
✅ Government support & infrastructure development.
✅ Opportunities for growth.
🔗 Explore the full report– Report
Digital & Brands:
- Longivetly is the biggest trend of 2025
- Microsoft plans to invest $3B in AI, cloud in India.
- Funding for Europe’s female founders declines for the third straight year.
- Microsoft has a ‘Google trick’ to keep people using its Bing search.
What’s trending this week in women’s health :
💰 Indian Funding News:
- Tata Capital Healthcare Fund, the healthcare and life sciences-focused private equity arm of financial services company Tata Capital, has invested $20 million in Harsoria Healthcare, a medical devices manufacturer.
- Nutraceutical firm Botanic Healthcare on Tuesday said it raised Rs 250 crore (about $30 million) in equity financing in a round led by Stakeboat Capital, with participation from co-investors Abakkus Four2Eight Opportunities Fund and DS Group, one of Stakeboat Capital’s LP.
💰 Global Funding News:
- Nema Health, a New Haven, CT-based provider of a solution for virtual trauma and PTSD care, raised $14.5M in Series A funding.
- Prudentia Sciences, a Cambridge, MA-based provider of an AI-powered technology platform for life sciences, raised $7M in funding.
- Coave Therapeutics, a Paris, France-based genetic medicines company, raised €32M in Series A funding. The round was led by Novo Holdings A/S and Bpifrance, with participation from Invus and UI Investissement, alongside existing investors Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital and Turenne Capital.
- Aspect Biosystems, a Vancouver, BC, Canada-based biotechnology company developing bioprinted tissue therapeutics for the regenerative medicine, raised US$115M in Series B funding.
- Aspect Biosystems, a Vancouver, BC, Canada-based biotechnology company developing bioprinted tissue therapeutics for the regenerative medicine, raised US$115M in Series B funding.
- Twentyeight Health, a digital-first women’s healthcare platform operating in 43 U.S. states, announced a $10 million Series A funding round led by Seae Ventures. The round included participation from Impact America Fund, The Social Entrepreneurs’ Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures, bringing the company’s total funding to $25 million.
📢 NEWS:
- AI might be able to boost the success rates of in vitro fertilization among hopeful families.An AI program can help doctors analyze ultrasound scans to determine the best timing for a hormone injection associated with egg collection, researchers write in a new study published Jan. 8 in the journal Nature Communications.
- Using a common antibiotic following sex can dramatically reduce a person’s risk of some sexually transmitted infections (STIs), a new study says.Taking doxycycline within 72 hours after sex reduced risk of chlamydia by 79%, syphilis by 80%, and gonorrhea by 12%, results published in JAMA Internal Medicine show.
- A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to help treat chronic pain and nerve pain, particularly as an alternative to opioid painkillers.
- Sugar-sweetened drink consumption accounts for more than 2 million new cases of type 2 diabetes, and 1.2 million new cases of heart disease worldwide annually.According to new research published Jan. 6 in the journal Nature Medicine, people all over the world are impacted by this growing problem. Colombia, Mexico, and South Africa have some of the worst sugar sweetened-beverage (SSB) related health problems.
- For many, coffee is a beloved morning ritual, fueling the day ahead. But what if the time you drink it could influence how long — and how well — you live?New research published Jan. 8 in the European Heart Journal suggests that when you enjoy your cup of Joe might be just as important as how much you drink.
- The Indian healthcare sector sees the emergence of medical networking to revolutionise quality services in remote regions. This is despite the resource and infrastructural constraints leading to the inaccessibility of healthcare services, creating pressing challenges for patients, especially in rural and remote areas.
- Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published in the Annals of Internal Medicine shows that the widely-known drugs tirzepatide (Zepbound) and semaglutide (Wegovy) are both safe and effective at helping the obese shed pounds.
- Fluoride exposure appears to slightly decrease IQ scores in children, a new federal meta-analysis has concluded — but not at the low levels recommended for U.S. drinking water. Fluoride in drinking water was associated with reduced IQ scores at levels of less than 4 milligrams per liter, but not at less than 1.5 mg/L, according to the analysis by researchers at the National Institute of Environmental Health Sciences.
- It’s long been a mystery why folks need a flu vaccine every year, even though immunizations they got in childhood continue to protect them from measles and mumps. Researchers now think they know why vaccine effectiveness varies — and they’ve even come up with a blood test to check a vaccine’s durability.
- Patients have more access to their own medical test results than ever before, thanks to legislation requiring results be released as soon as they’re available. But that’s not necessarily a good thing, a new study warns
🌐 Global Companies:
- ModeX Therapeutics Inc., an OPKO Health company, announced dosing of the first participant in the phase I study of an Epstein-Barr virus (EBV) vaccine candidate being developed in collaboration with Merck, known as MSD outside the United States and Canada. This development triggers an undisclosed cash milestone payment from Merck to ModeX.
- BlackfinBio Ltd (BFB), a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases, has announced that it has acquired the Parkinson’s patent portfolio from OXB.
- ScreenPoint Medical has announced the acquisition of Biomediq A/S, a research company specializing in quantitative imaging biomarkers. The acquisition follows a decade of collaboration between the companies on image-based risk assessment and aims to integrate breast cancer risk assessment capabilities into ScreenPoint’s Transpara Breast AI platform.
- UK-based health tech startup Elyfia has announced the launch of its digital health coaching platform designed specifically for individuals living with fibromyalgia. The app, now available on both Apple App Store and Google Play, aims to provide personalized support through a combination of human coaching and digital tools.
- Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for loteprednol etabonate ophthalmic gel, 0.38%, to market a generic equivalent of Lotemax SM ophthalmic gel of Bausch & Lomb Inc.
- Boehringer Ingelheim BioXcellence and Sutro Biopharma Inc. announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab tazevibulin, Sutro’s Tubulin FRa-targeting antibody-drug conjugate (ADC) designed to treat a broad range of patients with ovarian cancer and other FRa expressing cancers.
- In a new study published in Nature’s Digital Medicine journal, WHOOP researchers have introduced a new digital biomarker for monitoring menstrual cycles through wearable technology. The study, analyzing over 45,000 menstrual cycles from 11,590 participants, represents one of the largest investigations into cardiovascular changes across menstrual cycles using wearable technology.
- Women’s health technology company Elvie announced the launch of Elvie Rise, a smart bouncer that converts into a bassinet.
🇮🇳 Government News
- In order to establish Odisha as a global leader in pharmaceuticals, Odisha has unveiled a strategic action plan with the setting up of Odisha Pharmaceutical Development Cell (OPDC).
- The Parliamentary panel that reviewed the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has sought the Pharmaceuticals & Medical Devices Bureau of India (PMBI), the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), to take stringent measures to prevent any malpractices of the Jan Aushadhi Kendra (JAK) owners to the quality and safety of the medicines.
- Karnataka pharma industry is seeking improvements in the ease-of-doing business to attract greater investments into the state. While the state has a well-established pharmaceutical ecosystem, industry stakeholders believe streamlining regulatory processes, enhancing infrastructure, and offering incentives can bolster the sector’s growth and competitiveness.
- The Central Drugs Standard Control Organisation (CDSCO) has released an update on the existing risk based classification list of four categories, revisiting the existing list and adding new entries.
☀️ Stories we’re following this week!
📳 – Quick Reads:
- Caregivers Face Mental, Physical Health Risks: More and more adults are stuck in the middle of their families, caring not only for their children but also for aging parents and other older family members.
- Early Physical Therapy Key for Concussion Recovery, Study Shows: Turns out, starting physical therapy earlier after a concussion may significantly improve recovery outcomes.
- Taxi driving shields against death from Alzheimer’s?: A new study suggests that jobs demanding real-time navigational processing may reduce Alzheimer’s mortality risk.
See you next Friday, friends 👋
Navneet
[Sign up here to never miss on the latest updates.]